molecular imaging

Open Access
Superior Tumor Detection for ⁶⁸Ga-FAPI-46 Versus ¹⁸F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
Kim M. Pabst, Marija Trajkovic-Arsic, Phyllis F.Y. Cheung, Simone Ballke, Katja Steiger, Timo Bartel, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Robert Seifert, Michael Nader, Lukas Kessler, Jens T. Siveke, Katharina Lueckerath, Stefan Kasper, Ken Herrmann, Nader Hirmas, Hartmut H. Schmidt, Rainer Hamacher and Wolfgang P. Fendler

Journal of Nuclear Medicine April 6, 2023, jnumed.122.265215; DOI: https://doi.org/10.2967/jnumed.122.265215
You have access
Addition of Peptide Receptor Radiotherapy to Immune Checkpoint Inhibition Therapy Improves Outcomes in Neuroendocrine Tumors
Shadi A. Esfahani, Carolina De Aguiar Ferreira, Priska Summer, Umar Mahmood and Pedram Heidari

Journal of Nuclear Medicine April 6, 2023, jnumed.123.265391; DOI: https://doi.org/10.2967/jnumed.123.265391
You have access
Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
Stanley Fayn, A. Paden King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski, Ying Fu, Jessica Hong, Deepak Sail, Kwamena E. Baidoo, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter Choyke and Freddy Escorcia

Journal of Nuclear Medicine March 30, 2023, jnumed.122.265171; DOI: https://doi.org/10.2967/jnumed.122.265171
You have access
Prospective Phase II Trial of [⁶⁸Ga]Ga-NODAGA-E[c(RGDyK)]₂ PET/CT Imaging of Integrin α_vβ₃ for Prognostication in Patients with Neuroendocrine Neoplasms
Esben Andreas Carlsen, Mathias Loft, Annika Loft, Dorota Czyzewska, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer

Journal of Nuclear Medicine February 1, 2023, 64 (2) 252-259; DOI: https://doi.org/10.2967/jnumed.122.264383
You have access
Brain Trauma Imaging
Gérard N. Bischof and Donna J. Cross

Journal of Nuclear Medicine January 1, 2023, 64 (1) 20-29; DOI: https://doi.org/10.2967/jnumed.121.263293
You have access
Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging
Christian Schmidkonz, Torsten Kuwert, Armin Atzinger, Michael Cordes, Georg Schett, Andreas Ramming and Theresa Götz

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1786-1792; DOI: https://doi.org/10.2967/jnumed.122.264205
You have access
Nanoparticle Diagnostics and Theranostics in the Clinic
Roger M. Pallares, Felix M. Mottaghy, Volkmar Schulz, Fabian Kiessling and Twan Lammers

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1802-1808; DOI: https://doi.org/10.2967/jnumed.122.263895
You have access
Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma
Zhen Yang, Feng Li, Yuqian Huang, Na Yin, Junjun Chu, Ying Ma, Roderic I. Pettigrew, Dale J. Hamilton, Diego R. Martin and Zheng Li

Journal of Nuclear Medicine November 1, 2022, 63 (11) 1708-1714; DOI: https://doi.org/10.2967/jnumed.121.263151
You have access
Tracking Innate Immune Activation in a Mouse Model of Parkinson’s Disease Using TREM1 and TSPO PET Tracers
Katherine L. Lucot, Marc Y. Stevens, T. Adam Bonham, E. Carmen Azevedo, Aisling M. Chaney, Ebony D. Webber, Poorva Jain, Jessica L. Klockow, Isaac M. Jackson, Mackenzie L. Carlson, Edward E. Graves, Thomas J. Montine and Michelle L. James

Journal of Nuclear Medicine October 1, 2022, 63 (10) 1570-1578; DOI: https://doi.org/10.2967/jnumed.121.263039
You have access
Prospective Phase II Trial of Prognostication by ⁶⁸Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
Esben Andreas Carlsen, Mathias Loft, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer

Journal of Nuclear Medicine September 1, 2022, 63 (9) 1371-1377; DOI: https://doi.org/10.2967/jnumed.121.263177

Main menu

User menu

Search

molecular imaging

Pages